Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
about
Applications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular VirologyMiddle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak controlAnti-infective immunoadhesins from plants.Receptor-binding domain-based subunit vaccines against MERS-CoVCurrent advancements and potential strategies in the development of MERS-CoV vaccinesRational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations.Jumping species-a mechanism for coronavirus persistence and survival.MERS-CoV spike protein: a key target for antivirals.A review of treatment modalities for Middle East Respiratory Syndrome.A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants.Pre-fusion structure of a human coronavirus spike protein.Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide StrategyCryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domainsA conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.Structure, Function, and Evolution of Coronavirus Spike Proteins.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseDevelopment of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infectionsIntranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infectionLaboratory investigation and phylogenetic analysis of an imported Middle East respiratory syndrome coronavirus case in GreeceOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge.Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV InfectionCharacterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and DiseaseMicroevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike GlycoproteinsToward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection.Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.Vaccines for the prevention against the threat of MERS-CoV.Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapyUpdate on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: insights into mechanisms of general viral fusion and inhibitor design.MERS-coronavirus: From discovery to intervention.Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding.
P2860
Q26750838-C8852CFA-7AA8-4102-999D-7B686C06AAB5Q26796501-262EC953-6358-4EB0-B6EF-3C1E9AFF0BF6Q26799080-235FEBEF-0853-43CB-9866-CBF7C3B324C3Q26851979-AC79CA12-B0DA-4DC8-996A-7E87BC02B2A2Q27012578-48FBFE49-E640-4638-99E3-6C3D483E7637Q27315206-FF8A52DA-859E-41EE-9B5D-601121BB6514Q30235867-DF341BE4-9EA2-4929-85E7-A2E15DCD7D29Q30240139-21A25802-ED2E-4847-B90B-3753E545091FQ30248209-5FD06A6E-F0D1-40CC-A34A-B733D45AFC3AQ30379384-2BE2948A-F22F-4FC0-9F10-CAEABFA7F866Q30383672-5906374E-8336-4C75-8623-48927C1D1E85Q30385177-B99AAEEF-B0EF-4FD3-BD08-2A5EACF32E36Q30399700-E5CFAE20-2968-495E-900A-8AB0D24E3F19Q30661709-56393EC8-3C23-487E-8D43-2E8B5C3B166FQ30845557-1CDE2190-B155-4FF5-A201-62615253A7D3Q33743790-C727C3B4-03F4-412E-9CEE-F79FC40C9FBEQ33760875-C033B9C4-7E51-4A7B-B7CE-2A7DA318D14DQ34468689-1391D97C-0C3D-4F1F-B89C-D0485C3DB539Q35019893-59829BBD-D4BD-4C9C-9110-4924E1200D96Q35160026-DB17BD4F-5C50-4AA6-B87F-33125E2748EFQ35546907-D11E2F0B-31EB-4865-82A3-BE0DE004E406Q35887626-BCD0E8DC-ACD8-4B45-9BBF-1EAC5F06A4E5Q36252666-C5AD2D30-4B85-48CF-B2DC-4A19F9801C19Q36306931-1C420FEE-9418-4145-889A-34BDA7D2076AQ36433987-5DBC4220-D4C0-4ECF-83C0-B50DE9BE5E08Q36525303-85EC1140-6AC2-45DA-A5E2-A707B47B698FQ36643050-A2D3268F-E7C9-4D6F-9C0F-F5A30FED6E55Q36950903-AF954B4D-8726-4902-8604-AC4CE0B59DC8Q37169882-FB5439D2-4BDD-4FD0-AA1C-8FCDCE31D0A8Q37188934-FFA36892-CD8E-403A-A5E4-F7034AD062DCQ37512915-0C38F416-5D9D-411C-A952-5D9D60179E03Q38157419-0200C316-F330-4C46-9915-C92A9C3DCDE4Q38778044-AB368116-F312-443B-81F6-110DDC787516Q38993000-EC8D9E28-1A83-49EB-BC7C-164D4E54E64BQ39034541-FD659022-4DDE-4A6C-A7F9-F91728F3C33CQ39095556-8A941A69-8C17-4FEB-AFCB-B3C9ED212E5AQ39374922-DB802CE3-43EA-43CC-B7B4-134A2E6E8512Q40041480-8E4444AC-545B-4EAC-9727-6908F3015164Q40359845-AF55E208-A985-419D-86A8-BE4A97CA7A8CQ40397876-FFDA247B-4402-4822-8613-75F967815B1B
P2860
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@ast
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@en
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@nl
type
label
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@ast
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@en
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@nl
prefLabel
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@ast
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@en
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@nl
P2093
P2860
P50
P3181
P356
P1476
Structure-based discovery of M ...... e coronavirus fusion inhibitor
@en
P2093
Cuiqing Ma
Rongguang Zhang
P2860
P2888
P3181
P356
10.1038/NCOMMS4067
P407
P577
2014-01-01T00:00:00Z
P5875
P6179
1008179102